{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:09:54Z","timestamp":1791115794976,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/jcp.0b013e31803308ce","type":"journal-article","created":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T03:57:26Z","timestamp":1174276646000},"page":"166-170","source":"Crossref","is-referenced-by-count":57,"title":["Failed Efficacy of Fluoxetine in the Treatment of Posttraumatic Stress Disorder"],"prefix":"10.1097","volume":"27","author":[{"given":"Ferenc","family":"Martenyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen B.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine D.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.283.14.1837","article-title":"Efficacy and safety of sertraline treatment of posttraumatic stress disorder. A randomized controlled trial.","volume":"283","author":"Brady","year":"2000","journal-title":"JAMA"},{"key":"R3-8-20210128","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archpsyc.58.5.485","article-title":"Multicenter, double blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.","volume":"58","author":"Davidson","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"R4-8-20210128","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1176\/appi.ajp.158.12.1982","article-title":"Efficacy and safety of paroxetine treatment of chronic PTSD: a fixed-dose, placebo-controlled study.","volume":"158","author":"Marshall","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R5-8-20210128","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4088\/JCP.v62n1105","article-title":"Paroxetine in the treatment of chronic posttraumatic stress disorder. Results of a placebo-controlled, flexible-dose titration trial.","volume":"62","author":"Tucker","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R6-8-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1192\/bjp.175.1.17","article-title":"Fluoxetine in posttraumatic stress disorder: randomised, double-blind study.","volume":"175","author":"Connor","year":"1999","journal-title":"Br J Psychiatry"},{"issue":"3","key":"R7-8-20210128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.jcp.0000222514.71390.c1","article-title":"Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.","volume":"26","author":"Davinson","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archpsyc.1990.01810150059010","article-title":"Treatment of posttraumatic stress disorder with amitriptyline and placebo.","volume":"47","author":"Davidson","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005053-199106000-00011","article-title":"Pharmacotherapy for post-traumatic stress disorder using phenelzine or imipramine.","volume":"179","author":"Kosten","year":"1991","journal-title":"J Nerv Ment Dis"},{"issue":"4","key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/anxi.3070010404","article-title":"Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic.","volume":"1","author":"Katz","year":"1994","journal-title":"Anxiety"},{"issue":"4","key":"R11-8-20210128","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/BF02246271","article-title":"A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder.","volume":"122","author":"Baker","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"R12-8-20210128","first-page":"460","article-title":"Lack of efficacy for fluoxetine in PTSD: a placebo-controlled trial in combat veterans.","volume":"59","author":"Herzberg","year":"2000","journal-title":"Ann Clin Psychiatry"},{"key":"R13-8-20210128","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/bmj.319.7217.1089","article-title":"Sertraline approved for post-traumatic stress disorder.","volume":"319","author":"Gottlieb","year":"1999","journal-title":"BMJ"},{"issue":"3","key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4088\/JCP.v63n0305","article-title":"Fluoxetine versus placebo in post-traumatic stress disorder.","volume":"63","author":"Martenyi","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R16-8-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jts.2490080106","article-title":"The development of a clinician administered PTSD scale.","volume":"8","author":"Blake","year":"1995","journal-title":"J Trauma Stress"},{"key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"issue":"1","key":"R19-8-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004850-199701000-00006","article-title":"The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder.","volume":"12","author":"Davidson","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"R20-8-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1017\/S0033291796004229","article-title":"Assessment of a new self-rating scale for post-traumatic stress disorder.","volume":"27","author":"Davidson","year":"1997","journal-title":"Psychol Med"},{"key":"R21-8-20210128","first-page":"50","article-title":"The assessment of anxiety states by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Psychiatry"},{"issue":"12","key":"R22-8-20210128","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00005053-198612000-00004","article-title":"Development, reliability, and validity of a dissociation scale.","volume":"174","author":"Bernstein","year":"1986","journal-title":"J Nerv Ment Dis"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e31803308ce","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:35:23Z","timestamp":1786034123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200704000-00008"}},"subtitle":["Results of a Fixed-Dose, Placebo-Controlled Study"],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31803308ce","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}